Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy S Duffield

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Science Translational Medicine|February 2, 2018
Tissue-resident mesenchymal stromal cells: Implications for tissue-specific antifibrotic therapiesDario R Lemos, Jeremy S Duffield
Kidney International|October 14, 2005
Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injuryJeremy S Duffield, Joseph V Bonventre
Kidney International Supplements|August 28, 2015
The FOXD1 lineage of kidney perivascular cells and myofibroblasts: functions and responses to injuryIvan G Gomez, Jeremy S Duffield
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2017
What can target kidney fibrosis?Irina A Leaf, Jeremy S Duffield
Drug News & Perspectives|July 7, 2010
PRM-151 (recombinant human serum amyloid P/pentraxin 2) for the treatment of fibrosisJeremy S Duffield, Mark L Lupher
Nature Reviews. Drug Discovery|July 15, 2021
The glomerular filtration barrier: a structural target for novel kidney therapiesIlse S Daehn, Jeremy S Duffield
Biochimica Et Biophysica Acta|December 11, 2012
Resident mesenchymal cells and fibrosisNicol Hutchison, Cécile Fligny, Jeremy S Duffield
Drug Discovery Today. Disease Models|July 15, 2014
MicroRNAs are potential therapeutic targets in fibrosing kidney disease: lessons from animal modelsJeremy S Duffield, Monica Grafals, Didier Portilla
The Journal of Pathology|October 26, 2012
Wnt signalling in kidney diseases: dual roles in renal injury and repairTakahisa Kawakami, Shuyu Ren, Jeremy S Duffield
Pediatric Nephrology (Berlin, Germany)|February 12, 2011
The origin of interstitial myofibroblasts in chronic kidney diseaseIvica Grgic, Jeremy S Duffield, Benjamin D Humphreys
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Science Translational Medicine|February 2, 2018
Tissue-resident mesenchymal stromal cells: Implications for tissue-specific antifibrotic therapiesDario R Lemos, Jeremy S Duffield
Kidney International|October 14, 2005
Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injuryJeremy S Duffield, Joseph V Bonventre
Kidney International Supplements|August 28, 2015
The FOXD1 lineage of kidney perivascular cells and myofibroblasts: functions and responses to injuryIvan G Gomez, Jeremy S Duffield
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2017
What can target kidney fibrosis?Irina A Leaf, Jeremy S Duffield
Drug News & Perspectives|July 7, 2010
PRM-151 (recombinant human serum amyloid P/pentraxin 2) for the treatment of fibrosisJeremy S Duffield, Mark L Lupher
Nature Reviews. Drug Discovery|July 15, 2021
The glomerular filtration barrier: a structural target for novel kidney therapiesIlse S Daehn, Jeremy S Duffield
Biochimica Et Biophysica Acta|December 11, 2012
Resident mesenchymal cells and fibrosisNicol Hutchison, Cécile Fligny, Jeremy S Duffield
Drug Discovery Today. Disease Models|July 15, 2014
MicroRNAs are potential therapeutic targets in fibrosing kidney disease: lessons from animal modelsJeremy S Duffield, Monica Grafals, Didier Portilla
The Journal of Pathology|October 26, 2012
Wnt signalling in kidney diseases: dual roles in renal injury and repairTakahisa Kawakami, Shuyu Ren, Jeremy S Duffield
Pediatric Nephrology (Berlin, Germany)|February 12, 2011
The origin of interstitial myofibroblasts in chronic kidney diseaseIvica Grgic, Jeremy S Duffield, Benjamin D Humphreys
Pageof 11